George Jeffrey P. 4

What Happened
George Jeffrey P., an Outside Director of LENZ Therapeutics, was granted 22,100 derivative shares on June 15, 2026. The shares were issued at $0.00 (no cash paid). This was an award/grant (transaction code A), not an open-market purchase or sale.

Key Details

• Transaction date: 2026-06-15; reported in Form 4 filed 2026-06-15.
• Amount: 22,100 shares granted at $0.00 (derivative award).
• Shares owned after transaction: Not specified in this filing.
• Vesting/conditions (Footnote F1): 100% of the shares vest on the earlier of June 15, 2027 or the date of the next annual meeting of stockholders, provided the reporting person continues as an Outside Director per the company policy.
• Filing timeliness: Filing date equals the transaction date; appears timely.
• Transaction type: Award/grant of shares (derivative), not an exercise, purchase, sale, or gift.

Context
Director awards like this are typically part of non-cash compensation/retention and vest over time or upon service conditions. Because these shares are subject to vesting, they do not represent immediately transferable open-market purchases and should not be read as a direct buy/sell signal.